You are here
Le Conseil d’administration du Fonds mondial approuve une nouvelle tranche de 98 millions de dollars de subventions des allocations 2017/2019
Of the $98 million in country grants approved by Global Fund Board from 2017-2019 allocations, Latin America and Caribbean receive $57 million
This is the second of two articles in this issue on the grants recently approved by the Global Fund Board. In this article, we report on the comments of the Grant Approvals Committee (GAC) on four countries in the Latin American and Caribbean region: Belize, El Salvador, Panama and Paraguay.
On 12 November 2018, through electronic voting, the Global Fund Board approved $98.0 million in funding for 14 country grants from 13 countries. Of the 14 grants, four were for TB; three TB/HIV; three HIV; three malaria; and one TB/RSSH.
Tool developed by Global Fund and APMG Health used in transitioning countries to assess sustainability of services for key populations
Latin American and Caribbean (LAC) activists have been sounding the alarm for several years about what they perceive as systematic neglect of the region by the Global Fund. “We are the victims of our successes,” they say to highlight the fact that the Global Fund’s de-prioritization of the region is not a by-product of poor performance but rather a consequence of the current political climate.
“It is unlikely that Panama’s HIV-related civil society can effectively survive the exit of the Global Fund or gain a greater foothold as a full partner in [the] planning, implementation and monitoring of the national HIV response.” This is a key finding of the transition readiness assessment (TRA) report commissioned by the Panama country coordinating mechanism (CCM).